PDF herunterladen
PSYCH up2date 2019; 13(01): 23-33
DOI: 10.1055/a-0635-5567
Affektive Störungen
Georg Thieme Verlag KG Stuttgart · New York

Interaktion von Depression mit kardiovaskulären und metabolischen Erkrankungen

Michael Deuschle
,
Maria Gilles
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
04. Januar 2019 (online)

Auch verfügbar auf
    Lizenzen und Reprints Alle Artikel dieser Rubrik

Es besteht eine Wechselbeziehung zwischen Depression und körperlichen Erkrankungen. Besonders das metabolische Syndrom und die häufigen Stoffwechsel- und Gefäßerkrankungen zeigen eine höhere Prävalenz bei depressiven Patienten bzw. erhöhen das Risiko für eine Depression. Dieser Beitrag zeigt, welche Diagnostik notwendig ist und wie die Komorbiditäten berücksichtigt werden sollten.
Kernaussagen

  • Depression begünstigt das metabolische Syndrom, den Diabetes mellitus Typ 2 und Gefäßerkrankungen.

  • Bei manifester Gefäßerkrankung verschlechtert das Vorliegen einer Depression die Prognose.

  • Nach Herzinfarkt oder Schlaganfall treten gehäuft depressive Syndrome auf.

  • Eine Pharmakotherapie der Depression sollte keine kardiometabolischen Risiken und keine Wechselwirkung mit internistischer Medikation haben.

  • Patienten mit Depression haben ein erhöhtes kardiometabolisches Risiko und benötigen regelmäßiges Screening von metabolischen Laborparametern, Gewicht, Bauchumfang und Blutdruck.

Schlüsselwörter

Diabetes mellitus - Hypertonus - Dyslipidämie - metabolisches Syndrom - Post-Myokardinfarkt-Depression - Post-Stroke-Depression
 

  • Literatur

  • 1 Trautman S, Beesdo-Baum K. Behandlung depressiver Störungen in der primärärztlichen Versorgung. Dtsch Arztebl Int 2017; 114: 721-728
    PubMedGoogle Scholar
  • 2 Wiegand HF, Sievers C, Schillinger M. et al.. Major depression treatment in Germany – descriptive analysis of health insurance fund routine data and assessment of guideline-adherence. J Affect Disord 2016; 189: 246-253
    CrossrefPubMedGoogle Scholar
  • 3 Gaebel W, Kowitz S, Fritze J. et al.. Inanspruchnahme des Versorgungssystems bei psychischen Erkrankungen: Sekundärdaten von drei gesetzlichen Krankenkassen und der Deutschen Rentenversicherung Bund. Dtsch Arztebl Int 2013; 110: 799-808
    PubMedGoogle Scholar
  • 4 Kok GD, Bockting CL, Burger H. et al.. Double trouble: does co-morbid chronic somatic illness increase risk for recurrence in depression? A systematic review. PLoS One 2013; 8: e57510
    CrossrefPubMedGoogle Scholar
  • 5 Šprah L, Dernovšek MZ, Wahlbeck K. et al.. Psychiatric readmissions and their association with physical comorbidity: a systematic literature review. BMC Psychiatry 2017; 17: 1-17
    CrossrefPubMedGoogle Scholar
  • 6 Laursen TM, Musliner KL, Benros ME. et al.. Mortality and life expectancy in persons with severe unipolar depression. J Affect Disord 2016; 193: 203-207
    CrossrefPubMedGoogle Scholar
  • 7 Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: A meta-review. World Psychiatry 2014; 13: 153-160
    CrossrefPubMedGoogle Scholar
  • 8 Farmer A, Korszun A, Owen MJ. et al.. Medical disorders in people with recurrent depression. Br J Psychiatry 2008; 192: 351-355
    CrossrefPubMedGoogle Scholar
  • 9 Wulsin LR, Singal B. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 2003; 65: 201-210
    CrossrefPubMedGoogle Scholar
  • 10 Vancampfort D, Stubbs B, Mitchell AJ. et al.. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: A systematic review and meta-analysis. World Psychiatry 2015; 14: 339-347
    CrossrefPubMedGoogle Scholar
  • 11 Moussavi S, Chatterji S, Verdes E. et al.. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370: 851-858
    CrossrefPubMedGoogle Scholar
  • 12 Ali S, Stone M, Skinner TC. et al.. The association between depression and health-related quality of life in people with type 2 diabetes : a systematic literature review. Diabetes Metab Res Rev 2010; 26: 75-89
    CrossrefPubMedGoogle Scholar
  • 13 Lichtman JH, Froelicher ES, Blumenthal JA. et al.. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: Systematic review and recommendations: A scientific statement from the American Heart Association. Circulation 2014; 129: 1350-1369
    CrossrefPubMedGoogle Scholar
  • 14 Pan A, Keum N, Okereke OI. et al.. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 2012; 35: 1171-1180
    CrossrefPubMedGoogle Scholar
  • 15 van Reedt Dortland A, Giltay E, van Veen T. et al.. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand 2010; 122: 30-39
    PubMedGoogle Scholar
  • 16 Penninx BW. Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev 2017; 74: 277-286
    CrossrefPubMedGoogle Scholar
  • 17 Vogelzangs N, Beekman AT, van Reedt Dortland AK. et al.. Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users. Neuropsychopharmacoloy 2014; 39: 1624-1634
    Google Scholar
  • 18 Deuschle M. Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults. Curr Opin Psychiatry 2013; 26: 60-65
    CrossrefPubMedGoogle Scholar
  • 19 Hiles SA, Révész D, Lamers F. et al.. Bidirectional prospective associations of metabolic syndrome components with depression, anxiety, and antidepressant use. Depress Anxiety 2016; 33: 754-764
    CrossrefPubMedGoogle Scholar
  • 20 Fugger G, Dold M, Bartova L. et al.. Comorbid thyroid disease in patients with major depressive disorder – results from The European Group for the Study of Resistant Depression (GSRD). Eur Neuropsychopharmacol 2018; 28: 752-760
    CrossrefPubMedGoogle Scholar
  • 21 Egede L, Zheng D. Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care 2003; 26: 104-111
    CrossrefPubMedGoogle Scholar
  • 22 Deuschle M, Schweiger U. [Depression and diabetes mellitus type 2]. Nervenarzt 2012; 83: 1410-1422
    CrossrefPubMedGoogle Scholar
  • 23 Meijer A, Conradi H, Bos E. et al.. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011; 33: 203-216
    CrossrefPubMedGoogle Scholar
  • 24 Cohen H, Gibson G, Alderman M. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 2000; 108: 2-8
    PubMedGoogle Scholar
  • 25 Wu CS, Tsai YT, Hsiung CA. et al.. Comparative risk of ventricular arrhythmia and sudden cardiac death across antidepressants in patients with depressive disorders. J Clin Psychopharmacol 2017; 37: 32-39
    CrossrefPubMedGoogle Scholar
  • 26 Shin D, Oh Y, Eom CS. et al.. Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis. J Neurol 2014; 261: 686-695
    CrossrefPubMedGoogle Scholar
  • 27 Hiles SA, Lamers F, Milaneschi Y. et al.. Sit, step, sweat: longitudinal associations between physical activity patterns, anxiety and depression. Psychol Med 2017; 47: 1466-1477
    CrossrefPubMedGoogle Scholar